piboserod has been researched along with ml 10375 in 1 studies
Studies (piboserod) | Trials (piboserod) | Recent Studies (post-2010) (piboserod) | Studies (ml 10375) | Trials (ml 10375) | Recent Studies (post-2010) (ml 10375) |
---|---|---|---|---|---|
119 | 5 | 53 | 6 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armstrong, SR; Beattie, DT; Humphrey, PP; Mai, N; Marquess, D; McCullough, JL; Pulido-Rios, T; Richardson, C; Sandlund, C; Smith, JA; Vickery, RG | 1 |
1 other study(ies) available for piboserod and ml 10375
Article | Year |
---|---|
The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.
Topics: Animals; Cell Membrane; Cells, Cultured; Colon; Cyclic AMP; Esophagus; Gastric Fundus; Gastrointestinal Transit; Guinea Pigs; In Vitro Techniques; Indoles; Male; Muscle Contraction; Muscle, Smooth; Pressure; Protein Binding; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin, 5-HT4; Serotonin Antagonists; Serotonin Receptor Agonists | 2004 |